Creative Medical Technology (NASDAQ:CELZ) Stock Passes Below 50-Day Moving Average – Here’s What Happened

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $1.50 and traded as low as $0.62. Creative Medical Technology shares last traded at $0.65, with a volume of 249,764 shares changing hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered Creative Medical Technology from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, July 31st. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Creative Medical Technology currently has a consensus rating of “Reduce”.

Creative Medical Technology Price Performance

The stock has a fifty day simple moving average of $1.43 and a 200-day simple moving average of $1.84. The company has a market capitalization of $3.17 million, a price-to-earnings ratio of -0.31 and a beta of 1.94.

Creative Medical Technology (NASDAQ:CELZ) last issued its quarterly earnings data on Friday, May 8th. The company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.01. As a group, equities analysts expect that Creative Medical Technology Holdings, Inc. will post -1.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Creative Medical Technology stock. Jane Street Group LLC bought a new stake in shares of Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 30,205 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned 1.17% of Creative Medical Technology as of its most recent SEC filing. 1.42% of the stock is currently owned by hedge funds and other institutional investors.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc (NASDAQ: CELZ) is a clinical‐stage biotechnology company focused on the development, manufacture and commercialization of exosome‐based therapies derived from human bone marrow mesenchymal stem cells. The company’s proprietary exosome platform is being investigated for applications in regenerative medicine, aesthetic dermatology, wound healing and anti‐inflammatory treatments. Creative Medical leverages cGMP manufacturing processes to produce sterile, cell‐free exosome formulations designed to support tissue repair and cellular rejuvenation.

The company’s lead product candidates include XoFlo, an exosome enrichment product intended for use in musculoskeletal and soft tissue injuries, and specialized formulations targeting skin rejuvenation and scar reduction.